Solar A/s Stock Quote 0G33 - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
UK
LSE
Solar A/s (0G33) Quote

Solar A/s (0G33)

406.50

0.00

(0.00%)

Closed April 30 11:30AM

Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Current Price

406.50

Bid

0.00

Ask

0.00

Volume

144

0.00 Day's Range 0.00

406.50 52 Week Range 406.50

Market Cap

Previous Close

406.50

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

573

Shares Outstanding

6,460,000

Dividend Yield

-

PE Ratio

7.57

Earnings Per Share (EPS)

53.72

Revenue

13.03B

Net Profit

347M

Sector

Electronic Components, Nec

Industry

Diversified Investment Holding

Website

www.solarholding.dk

Headquarters

Kolding, Dnk

Founded

1955

Solar A/s is listed in the Electronic Components sector of the London Stock Exchange with ticker 0G33. The last closing price for Solar A/s was kr406.50. Over the last year, Solar A/s shares have traded in a share price range of kr 406.50 to kr 406.50.

Solar A/s currently has 6,460,000 shares outstanding. The market capitalization of Solar A/s is kr2.63 billion. Solar A/s has a price to earnings ratio (PE ratio) of 7.57.

No. 6 2024 Course of Annual General Meeting

No. 6 2024 Course of Annual General Meeting The annual general meeting (AGM) took due note of the management’s review and discussed and approved the Annual Report 2023 together with the statement...

No. 6 2024 Share trading

No. 6 2024 Share trading In accordance with article 19 of Regulation (EU) No 596/2014, Solar is required to report share trading in Solar A/S of members of the Board of Directors, members of the...

No. 5 2024 Grant of performance shares

No. 5 2024 Grant of performance shares The Board of Directors of Solar A/S (the “Company”) has approved a new Long-Term Incentive Program (“LTIP”) for the members of Executive Management (the...

No. 4 2024 Notice of general meeting

No. 4 2024 Notice of general meeting The Annual General Meeting of Solar A/S will be held on Friday, 15 March 2024, at 11.00 am, at the address Industrivej Vest 43, 6600 Vejen, Denmark. The...

No. 3 2024 Annual Report 2023

No. 3 2024 Annual Report 2023 In 2023, we reached a revenue of DKK 13.0bn and an EBITDA DKK 0.9bn. EBITDA was in line with our guidance, whereas revenue came in below caused by a market slowdown...

No. 2 2024 Expectations for 2024 and preliminary results for 2023

No. 2 2024 Expectations for 2024 and preliminary results for 2023 In Q4 2023 and in the beginning of 2024, we saw a market slowdown. The slowdown is reflected in our 2024 guidance of a revenue of...

No. 1 2024 Hugo Dorph resigns his position as CCO

No. 1 2024 Hugo Dorph resigns his position as CCO By agreement, Hugo Dorph will leave his position as CCO and member of Solar's Executive Board today. Hugo Dorph has been member of the...

No. 12 2023 Financial calender 2024 for Solar

No. 12 2023 Financial calender 2024 for Solar Financial calendar 2024 for Solar DateEvent1 FebruaryShareholders’ deadline for submitting proposals for the agenda for the Annual General...

No. 6 2024 Course of Annual General Meeting

No. 6 2024 Course of Annual General Meeting The annual general meeting (AGM) took due note of the management’s review and discussed and approved the Annual Report 2023 together with the statement...

No. 6 2024 Share trading

No. 6 2024 Share trading In accordance with article 19 of Regulation (EU) No 596/2014, Solar is required to report share trading in Solar A/S of members of the Board of Directors, members of the...

No. 5 2024 Grant of performance shares

No. 5 2024 Grant of performance shares The Board of Directors of Solar A/S (the “Company”) has approved a new Long-Term Incentive Program (“LTIP”) for the members of Executive Management (the...

No. 4 2024 Notice of general meeting

No. 4 2024 Notice of general meeting The Annual General Meeting of Solar A/S will be held on Friday, 15 March 2024, at 11.00 am, at the address Industrivej Vest 43, 6600 Vejen, Denmark. The...

No. 3 2024 Annual Report 2023

No. 3 2024 Annual Report 2023 In 2023, we reached a revenue of DKK 13.0bn and an EBITDA DKK 0.9bn. EBITDA was in line with our guidance, whereas revenue came in below caused by a market slowdown...

No. 2 2024 Expectations for 2024 and preliminary results for 2023

No. 2 2024 Expectations for 2024 and preliminary results for 2023 In Q4 2023 and in the beginning of 2024, we saw a market slowdown. The slowdown is reflected in our 2024 guidance of a revenue of...

No. 1 2024 Hugo Dorph resigns his position as CCO

No. 1 2024 Hugo Dorph resigns his position as CCO By agreement, Hugo Dorph will leave his position as CCO and member of Solar's Executive Board today. Hugo Dorph has been member of the...

No. 12 2023 Financial calender 2024 for Solar

No. 12 2023 Financial calender 2024 for Solar Financial calendar 2024 for Solar DateEvent1 FebruaryShareholders’ deadline for submitting proposals for the agenda for the Annual General...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	406.5	406.5	406.5	570	406.5	DE
4	0	0	406.5	406.5	406.5	448	406.5	DE
12	0	0	406.5	406.5	406.5	573	406.5	DE
26	0	0	406.5	406.5	406.5	484	406.5	DE
52	0	0	406.5	406.5	406.5	670	406.5	DE
156	0	0	406.5	406.5	406.5	685	406.5	DE
260	0	0	406.5	406.5	406.5	648	406.5	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AKLIAkili Inc	$ 0.3852 (63.98%)	79.5M
IMCCIM Cannabis Corporation	$ 0.85 (51.79%)	340.3k
GMMGlobal Mofy Metaverse Ltd	$ 1.38 (48.34%)	73.16M
WGSGeneDx Holdings Corporation	$ 16.30 (48.18%)	5.73M
CYCCCyclacel Pharmaceuticals Inc	$ 1.9897 (46.30%)	19.46M
CETXCemtrex Inc	$ 1.24 (-30.34%)	324.43k
LICNLichen China Limited	$ 1.42 (-30.05%)	1M
NRXPNRX Pharmaceuticals Inc	$ 2.6769 (-24.59%)	728.8k
LGHLWLion Group Holding Ltd	$ 0.0057 (-18.57%)	52
TWGTop Wealth Group Holding Ltd	$ 1.14 (-17.99%)	312.09k
TSLATesla Inc	$ 185.28 (-4.52%)	88.2M
AGBAAGBA Group Holding Ltd	$ 3.0868 (31.35%)	85.2M
EGOXNext e GO NV	$ 0.0305 (10.51%)	83.52M
SQQQProShares UltraPro Short QQQ	$ 11.73 (3.71%)	80.58M
JAGXJaguar Health Inc	$ 0.2319 (11.49%)	79.87M

manibiotech

manibiotech 2 minutes ago

According to these posters GBM only affects millionaires

DarkPool

DarkPool 2 minutes ago

Looks like silver I think

Prudent Capitalist

Prudent Capitalist 2 minutes ago

Bingo! I am a lifelong conservative Republican also. What I find truly incredible, and outright disingenuous, is how the Trump/MAGA crowd is bashing the Trump Vaccines that went a long way toward stamping out the COVID epidemic and got it behind everyone. The vaccines were developed and approved u

Law of Averages

Law of Averages 2 minutes ago

Need to break .0015 to see this run.

newmedman

newmedman 2 minutes ago

What's your buddy Prager up to these days? Certainly not writing grade school class curriculum I hope.

https://twitter.com/TheRickWilson/status/1785283394718343569

jpike

jpike 2 minutes ago

Another $900,000 in orders to be shipped.

oldrogue

oldrogue 2 minutes ago

https://www.marijuanamoment.net/

Oldrogue

casper6

casper6 2 minutes ago

Dl's middle name should be expert market,
Dismal record- for whatever reason.

boi568

boi568 2 minutes ago

Anavex is in the pre-application process for an MAA.

AlwaysOptimistic

AlwaysOptimistic 2 minutes ago

All's good Al. Doing just fine. Thank you for the concern.

ALDRADJKD123

ALDRADJKD123 2 minutes ago

https://i.imgflip.com/8l4am2.jpg

retired early

retired early 2 minutes ago

It's ok to let the news out. I already have my motherload. :)

ducci1

ducci1 2 minutes ago

Looks like wants to tease the Fib 5073--- before the Gap Fill!----Wild & Wolly Day---Good $$$ !!!

scotty3371

scotty3371 3 minutes ago

Wrong. They have watched their patients have zero weapons against this cancer for decades. It will be prescribed for almost all patients that qualify.

cadillacdave

cadillacdave 3 minutes ago

The fact that Ford is a partner of NVDA, could potentially damage NVDA. Ford will look to spread the blame around for the crashes - operator error, faulty chips etc.

Difficult to say how these investigations work out.

janetcanada

janetcanada 3 minutes ago

💰️***BLEG- Link to the trades:.....
***https://ih.advfn.com/stock-market/USOTC/demand-brands-pk-BLEG/trades

💰️***From Barchart.....
https://www.barchart.com/stocks/quotes/BLEG/overview

rcaselli

rcaselli 3 minutes ago

https://imgur.com/a/oB0LYso

LMAO

DDR

DDR 3 minutes ago

I'm afraid you just blew any shred of credibility you might possibly have had with anyone here. Now I absolutely doubt that you even made any transaction at all. To claim to know you bought more than anyone else could even afford is laughable beyond description. Yes you finally did hit a nerve wi

Jetmek_03052

Jetmek_03052 3 minutes ago

Poo, get OVER yourself.

Stop talking about other posters and throwing around insults.

The FACT is that DC's competitors (if it can be said that DC is even in the same LEAGUE as them) have no issue showing who they represent. DBMM could also - it just chooses not to. A

Dubster watching

Dubster watching 3 minutes ago

Hmmmm
On watch…

Nighthawk_1

Nighthawk_1 3 minutes ago

Lots are being bought these days.

BigBadWolf

BigBadWolf 3 minutes ago

I'll let all do the math yet a high % of the float has traded hands over the past month
trade data shown below
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174330657

boi568

boi568 3 minutes ago

If the FDA were to involve itself in ending trials for efficacy, as you suggest, it would requires orders of magnitude of greater resources. This is not going to happen.

BlazingStocks

BlazingStocks 4 minutes ago

Looking really good on News yesterday...

$WRIT - WRIT Media Group Inc (OTC: WRIT) is pleased to announce the companys engagement to create, market, and sell licensed products and services within each of the following areas: publishing, toys, clothing, souvenirs, artwork, food and bev

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions